Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030573 | SCV000053248 | likely benign | Amyloidosis, hereditary systemic 1 | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Likely benign. |
Eurofins Ntd Llc |
RCV000723872 | SCV000203764 | uncertain significance | not provided | 2013-12-18 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000030573 | SCV000995464 | likely benign | Amyloidosis, hereditary systemic 1 | 2019-05-20 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001173305 | SCV001336389 | likely benign | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000723872 | SCV001865639 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000030573 | SCV002410868 | benign | Amyloidosis, hereditary systemic 1 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002321492 | SCV002609069 | benign | Cardiovascular phenotype | 2018-09-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000723872 | SCV003799548 | likely benign | not provided | 2023-11-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004549394 | SCV000303885 | benign | TTR-related disorder | 2022-08-29 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000244982 | SCV001919787 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000244982 | SCV001928246 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000723872 | SCV002036738 | likely benign | not provided | no assertion criteria provided | clinical testing |